A detailed history of Simplex Trading, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,233 shares of OVID stock, worth $924. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,233
Holding current value
$924
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$2.72 - $4.04 $3,353 - $4,981
1,233 New
1,233 $3,000
Q1 2023

Apr 27, 2023

BUY
$1.88 - $2.85 $793 - $1,202
422 New
422 $1,000
Q2 2022

Aug 03, 2022

BUY
$1.69 - $3.31 $167 - $327
99 New
99 $0
Q2 2021

Aug 12, 2021

SELL
$3.3 - $4.49 $302,999 - $412,262
-91,818 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$2.42 - $4.47 $132,780 - $245,259
54,868 Added 148.49%
91,818 $369,000
Q4 2020

Feb 02, 2021

BUY
$2.28 - $6.84 $84,246 - $252,738
36,950 New
36,950 $85,000

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $52.8M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.